Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving the transcription factor NF-κB in human osteosarcoma

Clinical Science

Volumn 110, Issue 6, 2006, Pages 645-654

  Felx, Mélanie ^a   Guyot, Marie Claude ^a   Isler, Marc ^b   Turcotte, Robert E ^c   Doyon, Josée ^b   Khatib, Abdel Majid ^d   Leclerc, Séverine ^a   Moreau, Alain ^a,e   Moldovan, Florina ^a,e  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d INSERM   (France)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Endothelin 1 (ET 1); ETA; Gelatinase; Matrix metalloproteinase (MMP); Nuclear factor B (NF B); Osteosarcoma

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; NORTHERN BLOTTING; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ZYMOGRAPHY;

ADOLESCENT; ADULT; ANTIOXIDANTS; BLOTTING, NORTHERN; BLOTTING, WESTERN; BONE NEOPLASMS; CELL LINE, TUMOR; CHILD; ENDOTHELIN-1; ENZYME ACTIVATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NF-KAPPA B; OSTEOSARCOMA; PYRROLIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; THIOCARBAMATES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR CELLS, CULTURED;

EID: 33744927706     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20050286     Document Type: Article

References (30)

1. Wittig, J. C., Bickels, J., Priebat, D. et al. (2002) Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am. Fam. Physician 65, 1123-1132
2. Gorlick, R., Anderson, P., Andrulis, I. et al. (2003) Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. Clin. Cancer Res. 9, 5442-5453
3. Ossowski, L. and Reich, E. (1983) Changes in malignant phenotype of a human carcinoma conditioned by growth environment. Cell 33, 323-333
4. Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M. and Shafie, S. (1980) Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature (London) 284, 67-68
5. Egeblad, M. and Werb, Z. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174
6. Bagnato, A., Salani, D., Di Castro, V. et al. (1999) Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth. Cancer Res. 59, 720-727
7. Nakamuta, M., Ohashi, M., Tabata, S. et al. (1993) High plasma concentrations of endothelin-like immunoreactivities in patients with hepatocellular carcinoma. Am. J. Gastroenterol. 88, 248-252
8. Nelson, J. B., Hedican, S. P., George, D. J. et al. (1995) Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat. Med. 1, 944-949
9. Ferrari-Bravo, A., Franciosi, C., Lissoni, P., Fumagalli, L. and Uggeri, F. (2000) Effects of oncological surgery on endothelin-1 secretion in patients with operable gastric cancer. Int. J. Biol. Markers 15, 56-57
10. Kusuhara, M., Yamaguchi, K., Nagasaki, K. et al. (1990) Production of endothelin in human cancer cell lines. Cancer Res. 50, 3257-3261
11. Ali, H., Dashwood, M., Dawas, K., Loizidou, M., Savage, F. and Taylor, I. (2000) Endothelin receptor expression in colorectal cancer. J. Cardiovasc. Pharmacol. 36, S69-S71
12. Yamashita, J., Ogawa, M., Inada, K., Yamashita, S., Matsuo, S. and Takano, S. (1991) A large amount of endothelin-1 is present in human breast cancer tissues. Res. Commun. Chem. Pathol. Pharmacol. 74, 363-369
13. Suzuki, T., Hoshi, N., Watanabe, K., Kasukawa, R. and Suzuki, T. (1998) Immunohistochemical localization of endothelin-1/big endothelin-1 in normal liver, liver cirrhosis and hepatocellular carcinoma. Fukushima J. Med. Sci. 44, 93-105
14. Rosano, L., Varmi, M., Salani, D. et al. (2001) Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells. Cancer Res. 61, 8340-8346
15. Roy-Beaudry, M., Martel-Pelletier, J., Pelletier, J. P. et al. (2003) Endothelin 1 promotes osteoarthritic cartilage degradation via matrix metalloprotease 1 and matrix metalloprotease 13 induction. Arthritis Rheum. 48, 2855-2864
16. Jones, L. J., Yue, S. T., Cheung, C. Y. and Singer, V. L. (1998) RNA quantitation by fluorescence-based solution assay: RiboGreen reagent characterization. Anal. Biochem. 265, 368-374
17. Lange, M., Pagotto, U., Hopfner, U. et al. (1994) Endothelin expression in normal human anterior pituitaries and pituitary adenomas. J. Clin. Endocrinol. Metab. 79, 1864-1870
18. Xu, P., Wang, Y., Piao, Y. et al. (2001) Effects of matrix proteins on the expression of matrix metalloproteinase-2, -9, and -14 and tissue inhibitors of metalloproteinases in human cytotrophoblast cells during the first trimester. Biol. Reprod. 65, 240-246
19. Chantrain, C. and DeClerck, Y. A. (2002) Les métalloproté ases matricielles et leurs inhibiteurs synthétiques dans la progression tumorale. Médecine/Sci. 18, 565-575
20. Tsuruda, T., Costello-Boerrigter, L. C. and Burnett, Jr, J. C. (2004) Matrix metalloproteinases: pathways of induction by bioactive molecules. Heart Fail. Rev. 9, 53-61
21. Lambert, E., Dasse, E., Haye, B. and Petitfrere, E. (2004) TIMPs as multifacial proteins. Crit. Rev. Oncol. Hematol. 49, 187-198
22. Morrison, C. J., Butler, G. S., Bigg, H. F., Roberts, C. R., Soloway, P. D. and Overall, C. M. (2001) Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway. J. Biol. Chem. 276, 47402-47410
23. Sounni, N. E., Janssen, M., Foidart, J. M. and Noel, A. (2003) Membrane type-1 matrix metalloproteinase and TIMP-2 in tumor angiogenesis. Matrix Biol. 22, 55-61
24. Egeblad, M. and Werb, Z. (2002) New functions for matrix metalloproteinases in cancer progression. Nat. Rev. 2, 161-174
25. Andela, V. B., Gordon, A. H., Zotalis, G. et al. (2003) NF-κB: a pivotal transcription factor in prostate cancer metastasis to bone. Clin. Orthop. Relat. Res. 415 (Suppl.), S75-S85
26. Meyer, M., Schreck, R. and Baeuerle, P. A. (1993) H2O2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12, 2005-2015
27. B receptor heterodimer. Cell. Mol. Neurobiol. 22, 207-226
28. Nambi, P., Wu, H. L., Lipshutz, D. and Prabhakar, U. (1995) Identification and characterization of endothelin receptors on rat osteoblastic osteosarcoma cells: down-regulation by 1,25-dihydroxy-vitamin D3. Mol. Pharmacol. 47, 266-271
29. Loukopoulos, P., O'Brien, T., Ghoddusi, M., Mungall, B. A. and Robinson, W. F. (2004) Characterisation of three novel canine osteosarcoma cell lines producing high levels of matrix metalloproteinases. Res. Vet. Sci. 77, 131-141
30. Bagnato, A. and Natali, P. G. (2004) Targeting endothelin axis in cancer. Cancer Treat. Res. 119, 293-314